Acquisition Announced Sponsor buyer
Timothy R. Damadian acquisition of FONAR
Announced 29 Dec 2025 · NASDAQ: FONR · US$19.00 cash per share
Advisers
FONAR
Target
- Legal adviser
- Meister Seelig & Fein PLLC
- Valuation
- Fairness opinion
FONAR
Acquirer
- Legal adviser
- Moritt Hock & Hamroff LLP
- Target
- FONAR
- Acquirer
- FONAR
- Sponsor
- Timothy R. Damadian
- Target based in
- United States
- Buyer based in
- United States (unverified)
- Sector
- Medtech
- Tags
- Medtech, Healthcare Services, Diagnostics
In the league tables
Similar deals
- Labcorp acquisition of Select assets of BioReference Health Oct 2026 · Diagnostics
- Hanger acquisition of Numotion Sep 2026 · Medtech
- Cardinal Health acquisition of Strive Medical Jul 2026 · Healthcare Services
- Halma acquisition of Dreampath Diagnostics Jul 2026 · Diagnostics
- Inflexion acquisition of Primed Group Jul 2026 · Healthcare Services
Sources
- 26 Feb 2026 Preliminary merger proxy statement (PREM14A), FONAR CORP sec.gov
- 16 Apr 2026 Definitive merger proxy statement (DEFM14A), FONAR CORP sec.gov